News
Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.
Transformative optogenetics technology allows for spatial and temporal control of cellular activity, enhancing research in ...
The vendor community represents a fascinating cross-section of humanity – retired collectors turning passions into side businesses, professional dealers with encyclopedic knowledge, families clearing ...
Navigate the world of plug-in hybrids with ease, from smart charging tips to simple road trip planning that helps you stay on electric power.
Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are ...
It creates a reusable function that takes three inputs: actual sales, sales quota, and a weighting factor. It returns a weighted performance score by dividing sales by quota and multiplying by the ...
Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Katie Okamoto Katie Okamoto is an editor focusing on sustainability. She’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results